| 7411072 |
Tricyclic steroid hormone nuclear receptor modulators |
Michael J. Coghlan, Jonathan Edward Green, Prabhakar Kondaji Jadhav, Donald P. Matthews, Mitchell I. Steinberg +2 more |
2008-08-12 |
$92,020,000 |
| 7348359 |
Retinoid X receptor modulators |
Kevin Matthew Gardinier, Douglas Linn GERNERT, David Andrew Neel, Christopher M. Mapes, Pierre-Yves Michellys +1 more |
2008-03-25 |
|
| 7250442 |
Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators |
Matthew Brown, Prabhakar Kondaji Jadhav, David Andrew Neel, Mitchell I. Steinberg, Peter Ambrose Lander |
2007-07-31 |
$79,905,000 |
| 6861530 |
Piperidine derivatives |
Shinji Nara, Rieko Nakatsu, Yutaka Kanda, Shiro Akinaga, Mitsunobu Hara +2 more |
2005-03-01 |
$11,017,000 |
| 6417198 |
Methods of inhibiting CNS problems in post-menopausal women |
Henry U. Bryant, Andrew L. Glasebrook, David L. Phillips |
2002-07-09 |
$83,855,000 |
| 6133288 |
Pentacyclic compounds, intermediates, processes, compositions, and methods |
— |
2000-10-17 |
$162,752,000 |
| 6004971 |
Pentacyclic compounds, intermediates, processes, compositions, and methods |
— |
1999-12-21 |
$325,244,000 |
| 5998442 |
Benzo [B] thiophene compounds, and compositions for treating bone loss, and hyperlipidemia |
Stephen Yong Cho, Lewis D. Pennington |
1999-12-07 |
$63,132,000 |
| 5728724 |
Benzothiophene compounds |
Henry U. Bryant, Stephen Sung Yong Cho |
1998-03-17 |
$472,163,000 |
| 5726186 |
Pentacyclic compounds, intermediates, processes, compositions, and methods |
— |
1998-03-10 |
$68,267,000 |
| 5663184 |
Methods of inhibiting CNS problems in post-menopausal women |
Henry U. Bryant, Andrew L. Glasebrook, David L. Phillips |
1997-09-02 |
$91,225,000 |
| 5637598 |
Methods of inhibiting bone loss |
— |
1997-06-10 |
$51,241,000 |
| 5556876 |
Methods for lowering serum cholesterol |
Henry U. Bryant |
1996-09-17 |
$60,282,000 |
| 5552433 |
Method for lowering serum cholesterol |
Henry U. Bryant |
1996-09-03 |
$12,735,000 |
| 5521172 |
Methods for lowering serum cholesterol |
Henry U. Bryant |
1996-05-28 |
$29,088,000 |
| 5494929 |
Methods of inhibiting growth hormone effects |
— |
1996-02-27 |
$59,707,000 |
| 5482950 |
Methods for lowering serum cholesterol |
Henry U. Bryant |
1996-01-09 |
$47,013,000 |
| 5480904 |
Methods for inhibiting uterine fibrosis |
Henry U. Bryant |
1996-01-02 |
$27,404,000 |
| 5446071 |
Methods for lowering serum cholesterol |
— |
1995-08-29 |
$18,784,000 |
| 5446061 |
Methods for lowering serum cholesterol |
Henry U. Bryant |
1995-08-29 |
$18,784,000 |
| 5441964 |
Methods for inhibiting bone loss using substituted benzothiophene |
Henry U. Bryant |
1995-08-15 |
$12,577,000 |
| 5407947 |
Methods for inhibiting bone loss using pyrolidine and piperidine substituted benzopyrans |
Henry U. Bryant |
1995-04-18 |
$41,062,000 |
